Biogenic amines and the psychopharmacology of aggression
Expert Opinion on Therapeutic Patents, ISSN: 1354-3776, Vol: 8, Issue: 4, Page: 349-359
1998
- 4Citations
- 7Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Neurobiological research has implicated a wide variety of neurochemical agents in the modulation of aggressive behaviour patterns. The biogenic amines serotonin, noradrenaline and dopamine have been the focus of much of this research. Recent advances in neuroscience have facilitated understanding of biogenic amine neurotransmission in the regulation of aggressive agonistic behaviour patterns in animal and primate models, as well as human populations suffering from neuropsychiatric illness. This article reviews recent developments in the field, drawing on both the primary and recent patent literature. A rationale for considering pharmacological intervention when aggression occurs as symptom of neuropsychiatric illness is discussed based on new developments in biogenic amine receptor physiology.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know